NMR Surges Over 15% Following Numerai's $30M Series C Funding at $500M Valuation
NMR briefly rose more than 15% to $12.17 on November 21, HTX market data show. The rally followed Numerai's completion of a $30 million Series C funding round at a $500 million valuation, led by a university endowment fund with participation from Union Square Ventures, Shine Capital, and Paul Tudor Jones.